Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118346) titled 'Clinical Study of the Yishen Tiaogan Formula for Improving Bone Metastases of Breast Cancer' on Feb. 4.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Longhua Hospital Shanghai University of Traditional Chinese Medicine
Condition:
Bone metastasis of breast cancer
Intervention:
Treatment group:The subjects were intervened with the postoperative formula for breast cancer and the formula for nourishing the kidney and regulating the liver. The ingredients of the kidney-Nourishing and liver-regulating formula are as follows: 12g of Cuscuta chinensis, 30g of Achyranthes bidentata, 15g o...